List of SBIR/STTR awards granted to RevBio, Inc
Name | Description | SBIR/STTR Award Recipient | Government Agency | Government Branch | Award Type | Contract Number (US Government) | Award Phase | Award Amount (USD) | Date Awarded | Official Website | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
A SBIR Phase II contract was awarded to RevBio, Inc in April, 2021 for $1,368,425.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44AG060881-02 | Phase II | 1,368,425 | April 1, 2021 | |||||||
A STTR Phase I contract was awarded to RevBio, Inc in April, 2018 for $197,470.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | STTR | 1R41AG060881-01A1 | Phase I | 197,470 | April 1, 2018 | |||||||
A SBIR Phase II contract was awarded to RevBio, Inc in May, 2020 for $1,325,488.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44NS115386-01A1 | Phase II | 1,325,488 | May 1, 2020 | |||||||
A SBIR Phase I contract was awarded to RevBio, Inc in September, 2019 for $300,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43DE029369-01 | Phase I | 300,000 | September 19, 2019 | |||||||
A SBIR Phase I contract was awarded to RevBio, Inc in August, 2022 for $375,000.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R43AG079741-01A1 | Phase I | 375,000 | August 15, 2022 | |||||||
A SBIR Phase II contract was awarded to RevBio, Inc in September, 2023 for $2,050,357.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 2R44DE029369-02 | Phase II | 2,050,357 | September 19, 2023 | |||||||
A SBIR Phase II contract was awarded to RevBio, Inc in June, 2023 for $1,265,448.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1R44DE032564-01 | Phase II | 1,265,448 | June 1, 2023 | |||||||
A SBIR Phase II contract was awarded to RevBio, Inc in September, 2023 for $1,746,739.0 USD from the U.S. Department of Health & Human Services and National Institutes of Health. | SBIR | 1SB1AG085803-01 | Phase II | 1,746,739 | September 30, 2023 |
